Conor Medsystems, Inc. And Cordis Corporation (JNJ) Release: Patient Enrollment Complete for Pivotal Trial of the NEVO(TM) Sirolimus-eluting Coronary Stent with Unique Reservoir Technology
10/27/2008 11:25:03 AM
More...
|
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, Inc., to its Board of Directors
8/5/2008 9:28:22 AM
More...
|
Conor Medsystems, Inc. Release: Clinical Trial Begins for Innovative Drug-Eluting Stent with Unique Reservoir Technology
3/27/2008 9:29:50 AM
More...
|
Angiotech Pharmaceuticals, Inc. (ANPI) Reaches Agreement with Johnson & Johnson (JNJ) to Settle Outstanding Patent Litigation
9/17/2007 2:45:52 PM
More...
|
Angiotech Pharmaceuticals, Inc. (ANPI) (Jobs), Conor Medsystems, Inc. (Jobs) Reach CoStar Stent Agreement
9/17/2007 6:38:57 AM
More...
|
Conor Medsystems, Inc. Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007
5/22/2007 2:37:53 PM
More...
|
Conor Medsystems, Inc. Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
5/7/2007 1:57:06 PM
More...
|
Conor Medsystems, Inc. To Present COSTAR II Data At EuroPCR
2/23/2007 2:49:05 PM
More...
|
Johnson & Johnson (JNJ) Completes Acquisition Of Conor Medsystems, Inc.
2/2/2007 11:44:59 AM
More...
|
Conor Medsystems, Inc. Stockholders Approve Merger Agreement With Johnson & Johnson (JNJ)
2/1/2007 10:20:07 AM
More...
|
|